Filing Details
- Accession Number:
- 0001209191-18-017545
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-06 19:55:53
- Reporting Period:
- 2018-03-02
- Accepted Time:
- 2018-03-06 19:55:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180262 | Herbalife Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615466 | Jesus Alvarez | 800 W. Olympic Blvd. Los Angeles CA 90015 | Vp, General Manager, Mexico | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-03-02 | 299 | $92.81 | 2,085 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-03-05 | 5,873 | $30.44 | 7,958 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-05 | 1,897 | $94.72 | 6,061 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2018-03-05 | 1,392 | $94.72 | 4,669 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2018-02-02 | 5,873 | $0.00 | 5,873 | $30.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-03-02 | 2025-03-02 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $92.82 to $92.79. The price reported reflects the weighted average sale price of $92.81. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The reporting person received 2,584 shares of common stock upon the net exercise of 5,873 stock appreciation rights ("SARS"). The reporting person forfeited 1,897 shares of common stock underlying the SARS in payment of the exercise price and 1,392 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on March 5, 2018 of $94.27.
Billionaire Hedge Funds
